News | May 23, 2005

Respironics Releases BiPAP® S/T Ventilatory Support System

Murrysville, PA, – Respironics, Inc. announces the release of its BiPAP® S/T Ventilatory Support System, the newest addition to its home noninvasive ventilator fleet. The compact and lightweight unit is simple to operate offering a straightforward user interface and an integrated heated humidifier for easier set-up and management. The unit also is the first noninvasive device to combine Respironics' proven BiPAP® technology with SmartCard® for use with Encore® Pro and is rich with features such as Digital Auto-Trak™ Sensitivity™, adjustable RiseTime, and integrated alarms.

"The BiPAP S/T combines a simple design with sophisticated features that benefit both patients and clinicians," said Cheryl Needham, Product Manager, Home Ventilation, and Homecare Division. "Our Digital Auto-Trak feature helps to improve a patient's comfort while use with our SmartCard® and Encore® Pro helps clinicians gather and manage more accurate data."

Digital Auto-Trak Sensitivity™ is a feature that helps to recognize and compensate for unintentional and intentional leaks in a noninvasive system, and to automatically adjust to maintain optimum performance. Integrating the BiPAP S/T with Respironics' Encore® Pro with SmartCard® offers detailed compliance data to help clinicians understand a patient's usage and adherence to treatment.

Respironics' Homecare Division is recognized worldwide for its continuous stream of medical innovations and advancements in the management of sleep disorders, chronic respiratory problems, and neonatal and pediatric care. The Division integrates state-of-the-art technology in diagnostics, therapy and monitoring with strategic programs to help health care providers, sleep centers and pediatric units care for patients efficiently and cost-effectively.

Respironics is a leading developer, manufacturer and distributor of innovative products and programs that serve the global sleep and respiratory markets. Focusing on emerging market needs, the Company is committed to providing valued solutions to help improve outcomes for patients, clinicians and healthcare providers. Respironics markets its products in over 125 countries and employs more than 3,800 associates worldwide. Further information can be found on the Company's Web site: www.respironics.com.

Source: Respironics